Recall Register

Food, drugs, devices › Becton Dickinson & Co.

Device recall: BD FocalPoint Slide Profiler and BD FocalPoint GS Review Station; Catalog Nos. 490398, 490653, 491085, 491086, 491090, 4

FDA enforcement event 81097 · Class III · initiated 21 Sep 2018 · status Terminated · terminated 25 Apr 2019

DeviceVoluntary: Firm initiated1 product recordSparks, MD

Becton Dickinson & Co. (Sparks, MD) initiated this device recall on 21 Sep 2018; FDA lists 1 product record under event 81097, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 4% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 25 Apr 2019. Initiation: voluntary: firm initiated. Becton Dickinson & Co. has 77 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Becton Dickinson & Co., Sparks, MD.

Reason for recall

"The device may not function at the lower end (<15 deg. C) of the labeled operating temperatures. The instrument returns to normal operating conditions when environmental temperatures are at or above 15 deg. C. This issue has no potential to cause harm to either the patient or the operator. At the lower temperature, the instrument may fail to initialize, in which case slides would require manual…"

Distribution

"Worldwide distribution: US (Nationwide) and to countries of: Korea, Australia, Japan, Malaysia, Canada, Brazil, and Belgium."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0081-2019BD FocalPoint Slide Profiler and BD FocalPoint GS Review Station; Catalog Nos. 490398, 490653, 491085, 491086, 491090, 490189 The BD FocalPoint GS Imaging System is intended to assist in cervical cancer screening of BD SurePath Liquid-based Pap Test slides to detect evidence of squamous carcinoma, adenocarcinoma and…1063Class IIITerminated17 Oct 2018

Context

4%of 2018 device events are Class III1,074 events that year
1product record in this eventfirm median: 1
77events on this register for the firm

Other enforcement events for Becton Dickinson & Co.

InitiatedProduct (first record)TypeClassRecords
7 Apr 2026BD GasPak EZ CO2 Pouch System. Catalog Number: 260684. for microbiologic useDeviceClass II2
23 Oct 2025BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100;DeviceClass II1
23 Sep 2025BD EpiCenter Microbiology Data Management System, labeled as the following: 1. Computer System Epicenter F/G, Catalog NuDeviceClass II6
23 Jun 2025BD COR System Software. Model Number: 444829.DeviceClass II1
20 May 2025BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culDeviceClass II1
12 Feb 2025BD BBL TB Stain Kit K, Catalog (REF): 212522DeviceClass II1
19 Dec 2024BD PCR Cartridges used with MAX System. Model Number: 437519DeviceClass II1
6 Nov 2024BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) are used for semi-quantitatDeviceClass II1
31 Oct 2024BD EpiCenter Single User Software Version or Model: 441007 Catalog Number: 441007DeviceClass II13
12 Sep 2024BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone laboratory softDeviceClass II1

All 77 events for Becton Dickinson & Co.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The device may not function at the lower end (<15 deg. C) of the labeled operating temperatures. The instrument returns to normal operating conditions when environmental temperatures are at or above 15 deg. C. This issue has no potential to cause harm to either the patient or the operator. At the lower temperature, the instrument may fail to initialize, in which case slides would require manual…"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution: US (Nationwide) and to countries of: Korea, Australia, Japan, Malaysia, Canada, Brazil, and Belgium."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 25 Apr 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.